Background illustration for clinical trials search

Paid Clinical Trials Hayward

Discover 2,221 paid clinical trials in Hayward, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

for
Type 1 Diabetes
Location: San Francisco CA, Tacoma WA, Seattle WA, Albuquerque NM,
Sponsor: SAb Biotherapeutics, Inc.

Sex: All

Age: 5 - 40

Code: NCT07187531

Phase 2, Recruiting

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

for
Rheumatoid Arthritis, Interstitial Lung Disease
Location: San Francisco CA, Aurora CO, Kansas City KS,
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT06397677

Recruiting

Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs

for
Hepatitis C
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06179498

Recruiting

Venetoclax Basket Trial for High Risk Hematologic Malignancies

for
Myelodysplastic Syndromes, de Novo,
Location: San Francisco CA, Aurora CO, Chicago IL, Atlanta GA,
Sponsor: Andrew E. Place, MD

Sex: All

Age: 1 - 40

Code: NCT05292664

Phase 1, Recruiting

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

for
Liver Transplant
Location: San Francisco CA, Chicago IL, Cincinnati OH,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 3 - 13

Code: NCT07549503

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB

for
Von Willebrand Disease (VWD), Heavy Menstrual Bleeding (HMB)
Location: San Francisco CA, Orange CA, San Diego CA, Lexington KY,
Sponsor: Alnylam Pharmaceuticals

Sex: Female

Age: 16 - 45

Code: NCT07575308

Phase 2, Recruiting

Understanding Motivation in Parkinson's Patients Through Neurophysiology

for
Parkinson Disease, Deep Brain Stimulation, Motivation
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT05065151

Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

for
Dravet Syndrome
Location: San Francisco CA, Portland OR, Aurora CO, Fort Worth TX,
Sponsor: Encoded Therapeutics

Sex: All

Age: 0 - 17

Code: NCT05419492

Phase 1, Phase 2, Recruiting

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

for
Hepatoblastoma, Hepatocellular Carcinoma (HCC), Liver Neoplasms,
Location: San Francisco CA, Los Angeles CA, Orange CA, Boston MA
Sponsor: Eureka Therapeutics Inc.

Sex: All

Age: 1 - 21

Code: NCT04634357

Phase 1, Phase 2, Recruiting

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

for
Breast Cancer
Location: San Francisco CA, Houston TX, Chicago IL, Nashville TN,
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 18+

Code: NCT03990896

Phase 2, Recruiting

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

for
Alpha1-Antitrypsin Deficiency
Location: San Francisco CA, Los Angeles CA, La Jolla CA,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06165341

Phase 3, Recruiting

The JULI Registry--Hemp and Cannabis Observational Registry

for
Chronic Pain, Appetite Disorders, Neuropathy,
Location: San Jose CA, Los Gatos CA, Dallas TX, Nashville TN
Sponsor: Juva Life

Sex: All

Age: 21+

Code: NCT04726254

Recruiting

A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

for
AADC Deficiency
Location: San Francisco CA, Columbus OH
Sponsor: Krzysztof Bankiewicz

Sex: All

Age: 2+

Code: NCT02852213

Phase 1, Recruiting

Platform of Randomized Adaptive Clinical Trials in Critical Illness

for
Respiratory Insufficiency,
Location: San Francisco CA, Los Angeles CA, San Diego CA,
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05440851

Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

for
Lupus Nephritis
Location: San Francisco CA, Loma Linda CA, Aurora CO,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 5 - 17

Code: NCT05039619

Phase 2, Recruiting

A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors That Are MTAP Deficient
Location: San Francisco CA, Portland OR, Pittsburgh PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06130553

Phase 1, Phase 2, Recruiting

Water-based Activity to Enhance Recovery in Long COVID-19

for
Long COVID
Location: Palo Alto CA
Sponsor: VA Office of Research and Development

Sex: All

Age: 18 - 70+

Code: NCT06142253

Recruiting

Understanding Ketamine's Dissociative Effects (KD Study)

for
Epilepsy
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT04861051

Phase 1, Recruiting

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs

for
Degenerative Disc Disease (DDD)
Location: Walnut Creek CA, Santa Monica CA, Greenwood Village CO,
Sponsor: ReGelTec, Inc.

Sex: All

Age: 22 - 70+

Code: NCT06011551

Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: Dianthus Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06858579

Phase 3, Recruiting